Literature DB >> 12387190

Characteristics of repetitively assaultive patients: ten year analysis of the Assaulted Staff Action Program (ASAP).

Raymond B Flannery1, Stephen Rachlin, Andrew Walker.   

Abstract

The pre-incident components of CISM interventions focus on providing information on risk expectancy as well as cognitive and behavioral resources to enhance coping. This paper studied both the demographic and clinical variables of repetitively assaultive patients in a ten-year analysis of the Assaulted Staff Action Program (ASAP) in an attempt to enhance predictor variables that might be associated with repeat offenders and thus provide staff additional coping resources. Although the demographic variables offered little predictive information, the clinical variable of personal victimization was highly associated with subsequent repeat assault incidents. The methodological limitations, a proposal for a new research paradigm, and the power of pre-incident training initiatives are examined.

Entities:  

Mesh:

Year:  2002        PMID: 12387190

Source DB:  PubMed          Journal:  Int J Emerg Ment Health        ISSN: 1522-4821


  4 in total

Review 1.  Characteristics of American assaultive psychiatric patients: review of published findings, 2000-2012.

Authors:  Raymond B Flannery; Grace Wyshak; Joseph J Tecce; Georgina J Flannery
Journal:  Psychiatr Q       Date:  2014-09

2.  Safety skills of mental health workers: empirical evidence of a risk management strategy.

Authors:  Raymond B Flannery; Andrew P Walker
Journal:  Psychiatr Q       Date:  2003

Review 3.  Repetitively assaultive psychiatric patients: review of published findings, 1978-2001.

Authors:  Raymond B Flannery
Journal:  Psychiatr Q       Date:  2002

4.  Clinical and organizational factors related to the reduction of mechanical restraint application in an acute ward: an 8-year retrospective analysis.

Authors:  Rosaria Di Lorenzo; Fiorenza Miani; Vitantonio Formicola; Paola Ferri
Journal:  Clin Pract Epidemiol Ment Health       Date:  2014-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.